The Discounted Cash Flow (DCF) valuation of Samsung Biologics Co Ltd (207940.KS) is 484,021.36 KRW. With the latest stock price at 1,000,000.00 KRW, the upside of Samsung Biologics Co Ltd based on DCF is -51.6%.
Based on the latest price of 1,000,000.00 KRW and our DCF valuation, Samsung Biologics Co Ltd (207940.KS) is a sell. selling 207940.KS stocks now will result in a potential gain of 51.6%.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 7.5% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 289,318.17 - 1,506,959.82 | 484,021.36 |
| Upside | -71.1% - 50.7% | -51.6% |